๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hemolytic anemia associated with naproxen

โœ Scribed by J. A. Hughes; W. Sudell

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
105 KB
Volume
26
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hemolytic anemia associated with intrave
Hemolytic anemia associated with intravenous immunoglobulin
โœ John R. Wilson; Nirmala Bhoopalam; Morris Fisher ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 46 KB ๐Ÿ‘ 2 views

Intravenous immunoglobulin (IVIg) is a useful tool in the treatment of a variety of neuromuscular disorders. Though IVIg therapy is generally safe, hemolytic anemia is a potentially serious complication that is often overlooked, and is currently not listed in product inserts. We analyzed 45 patients

Autoimmune hemolytic anemia associated w
Autoimmune hemolytic anemia associated with colon cancer
โœ Akira B. Miura; Akira Shibata; Tetsuo Akihama; Yasuyuki Endo; Michiyoshi Sugawar ๐Ÿ“‚ Article ๐Ÿ“… 1974 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 382 KB ๐Ÿ‘ 2 views
Rituximab therapy for chronic lymphocyti
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
โœ Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 2 views

Autoimmune hemolytic anemia (AIHA) is a well-known complication of chronic lymphocytic leukemia (CLL). In recent years the anti-CD20 monoclonal antibody rituximab has been used for the therapy of steroid-refractory AIHA and autoimmune thrombocytopenia, either idiopathic or in association with CLL. W